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DISCUSSION

SUMMARY POINTS

History and Introduction
Febrile neutrophilic dermatosis, or Sweet’s syndrome, was first characterized by
Robert Sweet in 1964. The syndrome is characterized by fever, neutrophilia and
asymmetric skin lesions. The pathogenesis remains unclear; however, it is
believed to be a hypersensitivity reaction that leads to cytokine, auto-antibody
or immune complex formation which results in neutrophil activation and
infiltration.

Initial case presentation

CASE PRESENTATION
A 73 year old female presented with acute onset fever and right -sided facial
swelling, erythema and pain. She was initially diagnosed with facial cellulitis.
The patient was placed on a course of cephalexin; however, her symptoms
worsened, and she developed bilateral facial edema. Routine laboratory data
was not indicative of leukocytosis. An incision and drainage was performed and
minimal aspirate was retrieved; aspirate cultures were negative for bacterial and
fungal growth. The patient’s facial swelling continued to progress; she
developed bilateral peri-orbital edema, and she was intubated for airway
protection. The patient’s antibiotics were then broadened to vancomycin and
piperacillin-tazobactam, but after Infectious disease consultation, they were
changed to ampicillin-sulbactam and fluconazole. Repeat cultures performed
were again negative for any microorganisms. However, her symptoms did not
improve with antimicrobial therapy, so it was discontinued and a non-infectious
etiology was considered more likely. Rheumatology was consulted, but the
rheumatologic workup was negative. Then, Dermatology was consulted; they
performed a left cheek biopsy which showed perivascular and interstitial acute
and chronic inflammation of the dermis, and a diagnosis of febrile neutrophilic
dermatosis was made. Consequently, she was started on high-dose
corticosteroids, and her symptoms dramatically and rapidly improved.

Skin biopsy showing granulomatous inflammation of dermis with
neutrophils

Classification
1.Classical (idiopathic) Sweet’s syndrome
-Occurs typically in women in the age range of 30 to 60
-Typically follows an upper respiratory tract infection or gastroenteritis. Other
associated conditions include inflammatory bowel disease or pregnancy.
2. Malignancy-associated Sweet’s syndrome
-Occurs equally in men and women
-Most common malignancy: AML
-Dermatosis can precede, follow or appear concurrent with cancer
3. Drug-induced Sweet’s syndrome
-Most common drug: Granulocyte colony stimulating factor
Clinical Manifestations
-Fever, neutrophilia
-Asymmetric, tender erythematous skin lesions (papules, nodules or plaques).
Papules may have a clear vesicle-like appearance but on palpation are solid.
Lesions may be studded with pustules. Papules often coalesce into circinate or
arcuate plaques. Most frequent locations: upper extremities, face and neck
-Additionally there may be extracutaneous manifestations involving bone, CNS,
ears, eyes, mouth, heart, lung, kidneys, intestines, liver, spleen, and muscles.
Diagnosis
Criteria

Classic or Malignancy-associated

Drug induced

1 (Major)

Sudden onset of painful erythematous plaques or nodules

2 (Major)

Biopsy consistent with neutrophilic infiltrate without evidence of
leukocytoclastic vasculitis

3 (Minor)

Temperature > 38° C

4 (Minor)

Association with underlying
malignancy, inflammatory disease,
Relationship with drug ingestion and
pregnancy; or preceded by upper
clinical presentation; or recurrence
respiratory or gastrointestinal infection after oral challenge
or vaccination.

5 (Minor)

Excellent response to treatment with
systemic steroids or potassium iodide

6 (Minor)

Three of four of the following labs: ESR
> 20mm/hr, (+) C reactive protein, WBC
> 8000, neutrophils > 70 percent

Diagnosis

Both major criteria and two minor
criteria

Resolution of lesions after drug
withdrawal or treatment with systemic
steroids

All 5 criteria

Pathology
Typically shows inflammation and edema of dermis, with neutrophilic infiltrate.
Treatment
-First-line: systemic steroids: prednisone (1 mg/kg/day) for 4 weeks up to 6
months. Other agents: potassium iodide, colchicine
-Second-line: indomethacin, clofazimine, cyclosporine, dapsone

1. Sweet’ syndrome is characterized by fever, neutrophilia and asymmetric skin
lesions. It is classified into either classical, malignancy-associated, or druginduced based on associated factors.
2. It is diagnosed based on different major and minor criteria; however, diagnosis
is based primarily on tissue biopsy.
3. Treatment depends on the underlying cause, but systemic glucocorticoids are
the mainstay of therapy.
4. This patient had no malignancy, prior viral illness, and had not been taking any
medications that are typically associated with Sweet’s syndrome, which makes
this presentation unique.

Post steroid therapy

CONCLUSIONS
This case not only exemplifies the common diagnostic dilemma of limiting a
differential diagnosis but is also an unusual presentation of an already rare
syndrome.
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